Discovery of FLC-8 as the First Covalent FLT3 Inhibitor Targeting Cys807 for FLT3 Mutant Acute Myeloid Leukemia

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2026-04-03
DOI
https://doi.org/10.1021/acs.jmedchem.6c00511
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discovery of FLC-8 as the First Covalent FLT3 Inhibitor Targeting Cys807 for FLT3 Mutant Acute Myeloid Leukemia

Zhi‐Hao Shi, Zheng Wang, Jiao Cai, Xiaolong Jing et al.
Journal of Medicinal Chemistry
Acute Myeloid Leukemia Research
article

Discovery of FLC-8 as the First Covalent FLT3 Inhibitor Targeting Cys807 for FLT3 Mutant Acute Myeloid Leukemia

Zhi‐Hao Shi, Zheng Wang, Jiao Cai, Xiaolong Jing, Meng-Yuan Zhang, Qian Liu, Qing-Qing Li, Nian-Guang Li, Tong Xian
article en

Abstract

No abstract available for this paper.
Journal of Medicinal ChemistryVol. 69(8)
Nanjing University of Chinese Medicine (CN), China Pharmaceutical University (CN)
Openalex Percentile: Top 23%
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.